# Safety and Tolerability of AZD5148 in Japanese Participants

> **NCT06639997** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 16 (actual)

## Conditions studied

- Clostridioides Difficile Infection

## Interventions

- **DRUG:** AZD5148
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06639997
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-31
- **Primary completion:** 2025-12-25
- **Final completion:** 2025-12-25
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06639997

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06639997, "Safety and Tolerability of AZD5148 in Japanese Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06639997. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*